|
01 Aug 2025 |
L&T Technology
|
Consensus Share Price Target
|
4308.20 |
4581.41 |
- |
6.34 |
hold
|
|
|
|
|
18 Jul 2023
|
L&T Technology
|
Motilal Oswal
|
4308.20
|
4760.00
|
4067.70
(5.91%)
|
Target met |
Buy
|
|
|
|
|
27 Apr 2023
|
L&T Technology
|
Motilal Oswal
|
4308.20
|
4040.00
|
3731.00
(15.47%)
|
Target met |
Buy
|
|
|
|
|
20 Jan 2023
|
L&T Technology
|
Motilal Oswal
|
4308.20
|
3940.00
|
3230.70
(33.35%)
|
Target met |
Buy
|
|
|
|
|
19 Oct 2022
|
L&T Technology
|
ICICI Securities Limited
|
4308.20
|
3132.00
|
3675.10
(17.23%)
|
|
Sell
|
|
|
L&T Technology Services’ (LTTS) Q2FY23 revenue growth at 4.5% QoQ CC beat our estimate of 4%.
|
|
16 Jul 2022
|
L&T Technology
|
Motilal Oswal
|
4308.20
|
3590.00
|
3176.20
(35.64%)
|
Target met |
Buy
|
|
|
|
|
16 Jul 2022
|
L&T Technology
|
Prabhudas Lilladhar
|
4308.20
|
3184.00
|
3176.20
(35.64%)
|
Target met |
Hold
|
|
|
|
|
22 Apr 2022
|
L&T Technology
|
Arihant Capital
|
4308.20
|
3802.00
|
4068.80
(5.88%)
|
Target met |
Sell
|
|
|
|
|
22 Apr 2022
|
L&T Technology
|
Motilal Oswal
|
4308.20
|
5280.00
|
4101.40
(5.04%)
|
|
Buy
|
|
|
LTTS reported a 3.6% QoQ CC growth in 4QFY22, 90bp below our estimate due to softer growth in Industrial Products (-0.5% QoQ), Medical Devices (flat QoQ), and Telecom and Hi-Tech (+1.1% QoQ), while Transportation grew a robust 7.8% QoQ. Despite the large 400bp shift in its on-site revenue mix and lower utilization (-80bp QoQ), operating margin was flat QoQ. Attrition spiked to 20.4% (+290bp QoQ) in 4QFY22, indicating continued supply pressures. The company bagged its second over USD100m deal (after winning a historical first in Dec'21) from Jaunt Air Mobility in the Aerospace...
|
|
22 Apr 2022
|
L&T Technology
|
Prabhudas Lilladhar
|
4308.20
|
4549.00
|
4040.15
(6.63%)
|
|
Accumulate
|
|
|
estimates. We assume ~18% margins in FY23 & FY24. FY23 USD revenue growth guidance of 13.5-15.5% YoY USD appears to be conservative given pickup in large deal wins especially in EACV segment in FY22 and all-time large deal pipeline. However, given possibility of moderation in ER&D spends due to macro uncertainties, guidance may not be upgraded by same level as it was done in FY22 (upgraded from 13-15% to 19-20%). Management targets to maintain 18%+ EBIT margin factoring in headwinds from intermittent wage hikes, travel costs, high admin expenses...
|
|
20 Oct 2021
|
L&T Technology
|
Prabhudas Lilladhar
|
4308.20
|
5621.00
|
4564.85
(-5.62%)
|
Target met |
Buy
|
|
|
highest ever margin of 18.4% +116bps QoQ (Ple: 17.3%, Cons: 17%) despite high supply side cost pressures, driven by productivity gains and revenue growth leverage. We believe that margins may not sustain at these levels and will come back to ~17.3% in 2HFY22 given headwinds from rising attrition, probable wage hike and come-back of travel and facility costs. Deal traction was healthy with total 9 deals, 5 of these with TCV of USD10 million plus, which includes 2 USD25 million plus deals. Given strong demand momentum management has increased USD revenue growth guidance to 1920% from earlier 15-17% (previously 13-15%). Revenue guidance implies 3.54% sequential growth in Q3 and Q4. Management mentioned that they are...
|